PHARMA-TRADE A/S — Credit Rating and Financial Key Figures

CVR number: 87339815
Skaaremosevej 11-14, Blistrup 3230 Græsted
rsa@persano.dk

Income statement (kDKK)

2023
2024
Fiscal period length1212
Net sales
Gross profit
Costs of management-42.22-82.28
EBIT-42.22-82.28
Other financial income2 347.292 578.74
Other financial expenses-29.59- 116.17
Net income from associates (fin.)32 578.6741 294.46
Pre-tax profit34 854.1643 674.75
Income taxes- 500.43- 532.56
Net earnings34 353.7243 142.18

Assets (kDKK)

2023
2024
Intangible assets total
Tangible assets total
Holdings in group member companies175 436.16194 989.96
Investments total175 436.16194 989.96
Non-current loans receivable562.93550.67
Long term receivables total562.93550.67
Inventories total
Current amounts owed by group member comp.61 747.2463 279.53
Current other receivables5.3316.33
Current deferred tax assets8 709.0111 562.50
Short term receivables total70 461.5874 858.36
Cash and bank deposits4 943.912 407.61
Cash and cash equivalents4 943.912 407.61
Balance sheet total (assets)251 404.58272 806.60

Equity and liabilities (kDKK)

2023
2024
Share capital3 000.003 000.00
Shares repurchased30 000.0040 000.00
Other reserves120 445.86139 999.66
Retained earnings63 585.0046 644.26
Profit of the financial year34 353.7243 142.18
Shareholders equity total251 384.58272 786.10
Non-current liabilities total
Current trade creditors20.0020.50
Current liabilities total20.0020.50
Balance sheet total (liabilities)251 404.58272 806.60
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.